TNYA Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | Hoey Timothy | officer: Chief Scientific Officer | 245,346 | S-Sale | D | 3,300 | 7.00 | 23,101.00 |
| 2024-02-23 | Hoey Timothy | officer: Chief Scientific Officer | 248,646 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2024-02-23 | Hoey Timothy | officer: Chief Scientific Officer | 75,000 | A-Award | A | 75,000 | 5.22 | 391,500.00 |
| 2024-02-23 | Tingley Whittemore | officer: Chief Medical Officer | 215,000 | A-Award | A | 215,000 | 5.22 | 1,122,300.00 |
| 2024-02-23 | Tingley Whittemore | officer: Chief Medical Officer | 108,534 | A-Award | A | 35,000 | 0.00 | 0.00 |
| 2024-02-23 | PATTERSON LEONE D | officer: Chief Fin. and Bus. Officer | 205,000 | A-Award | A | 205,000 | 5.22 | 1,070,100.00 |
| 2024-02-23 | PATTERSON LEONE D | officer: Chief Fin. and Bus. Officer | 95,755 | A-Award | A | 35,000 | 0.00 | 0.00 |
| 2024-02-23 | Ali Faraz | director, officer: Chief Executive Officer | 505,000 | A-Award | A | 505,000 | 5.22 | 2,636,100.00 |
| 2024-02-23 | Ali Faraz | director, officer: Chief Executive Officer | 198,079 | A-Award | A | 85,000 | 0.00 | 0.00 |
| 2024-02-20 | Hoey Timothy | officer: Chief Scientific Officer | 236,346 | S-Sale | D | 6,369 | 5.31 | 33,813.00 |
| 2024-02-20 | Hoey Timothy | officer: Chief Scientific Officer | 236,146 | S-Sale | D | 200 | 6.17 | 1,233.00 |
| 2024-02-16 | Hoey Timothy | officer: Chief Scientific Officer | 242,715 | S-Sale | D | 4,681 | 5.86 | 27,431.00 |
| 2024-02-16 | Tingley Whittemore | officer: Chief Medical Officer | 73,534 | S-Sale | D | 6,500 | 5.86 | 38,090.00 |
| 2024-02-16 | PATTERSON LEONE D | officer: Chief Fin. and Bus. Officer | 60,755 | S-Sale | D | 5,201 | 5.86 | 30,478.00 |
| 2024-02-16 | Ali Faraz | director, officer: Chief Executive Officer | 113,079 | S-Sale | D | 6,358 | 5.86 | 37,258.00 |
| 2024-02-12 | COLUMN GROUP III GP, LP | 10 percent owner | 13,599,275 | P-Purchase | A | 2,222,222 | 4.50 | 9,999,999.00 |
| 2024-02-12 | GOEDDEL DAVID V | director, 10 percent owner: | 13,599,275 | P-Purchase | A | 2,222,222 | 4.50 | 9,999,999.00 |
| 2023-08-29 | Hoey Timothy | officer: Chief Scientific Officer | 247,396 | S-Sale | D | 7,243 | 4.26 | 30,855.00 |
| 2023-08-16 | Hoey Timothy | officer: Chief Scientific Officer | 254,639 | S-Sale | D | 4,007 | 3.81 | 15,267.00 |
| 2023-08-16 | Tingley Whittemore | officer: Chief Medical Officer | 76,437 | S-Sale | D | 5,563 | 3.81 | 21,195.00 |
| 2023-08-16 | PATTERSON LEONE D | officer: Chief Fin. and Bus. Officer | 64,542 | S-Sale | D | 4,452 | 3.81 | 16,962.00 |
| 2023-08-16 | Ali Faraz | director, officer: Chief Executive Officer | 119,437 | S-Sale | D | 5,563 | 3.81 | 21,195.00 |
| 2023-06-09 | Walsh Jeffrey T. | director | 29,532 | A-Award | A | 29,532 | 7.12 | 210,268.00 |
| 2023-06-09 | Williams R Sanders | director | 29,532 | A-Award | A | 29,532 | 7.12 | 210,268.00 |
| 2023-06-09 | Stehman-Breen Catherine | director | 29,532 | A-Award | A | 29,532 | 7.12 | 210,268.00 |
| 2023-06-09 | Srivastava Deepak | director | 29,532 | A-Award | A | 29,532 | 7.12 | 210,268.00 |
| 2023-06-09 | Parschauer Karah Herdman | director | 29,532 | A-Award | A | 29,532 | 7.12 | 210,268.00 |
| 2023-06-09 | Lee June | director | 29,532 | A-Award | A | 29,532 | 7.12 | 210,268.00 |
| 2023-06-09 | GOEDDEL DAVID V | director, 10 percent owner: | 29,532 | A-Award | A | 29,532 | 7.12 | 210,268.00 |
| 2023-06-09 | CHEN JIN-LONG | director | 29,532 | A-Award | A | 29,532 | 7.12 | 210,268.00 |
| 2023-06-09 | Burroughs Amy L. | director | 14,766 | A-Award | A | 14,766 | 7.12 | 105,134.00 |
| 2023-03-10 | COLUMN GROUP III GP, LP | 10 percent owner | 11,377,053 | P-Purchase | A | 6,779 | 2.60 | 17,596.00 |
| 2023-03-10 | GOEDDEL DAVID V | director, 10 percent owner: | 11,377,053 | P-Purchase | A | 6,779 | 2.60 | 17,596.00 |
| 2023-02-15 | Hoey Timothy | officer: Chief Scientific Officer | 258,646 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2023-02-15 | Hoey Timothy | officer: Chief Scientific Officer | 228,646 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2023-02-15 | Hoey Timothy | officer: Chief Scientific Officer | 175,000 | A-Award | A | 175,000 | 3.06 | 535,500.00 |
| 2023-02-15 | Tingley Whittemore | officer: Chief Medical Officer | 205,000 | A-Award | A | 205,000 | 3.06 | 627,300.00 |
| 2023-02-15 | Tingley Whittemore | officer: Chief Medical Officer | 80,000 | A-Award | A | 45,000 | 0.00 | 0.00 |
| 2023-02-15 | Tingley Whittemore | officer: Chief Medical Officer | 35,000 | A-Award | A | 35,000 | 0.00 | 0.00 |
| 2023-02-15 | PATTERSON LEONE D | officer: Chief Fin. and Bus. Officer | 190,000 | A-Award | A | 190,000 | 3.06 | 581,400.00 |
| 2023-02-15 | PATTERSON LEONE D | officer: Chief Fin. and Bus. Officer | 67,000 | A-Award | A | 35,000 | 0.00 | 0.00 |
| 2023-02-15 | PATTERSON LEONE D | officer: Chief Fin. and Bus. Officer | 32,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2023-02-15 | Ali Faraz | director, officer: Chief Executive Officer | 675,000 | A-Award | A | 675,000 | 3.06 | 2,065,500.00 |
| 2023-02-15 | Ali Faraz | director, officer: Chief Executive Officer | 125,000 | A-Award | A | 125,000 | 0.00 | 0.00 |
| 2023-02-08 | COLUMN GROUP III GP, LP | 10 percent owner | 11,370,274 | P-Purchase | A | 1,500,000 | 2.60 | 3,900,000.00 |
| 2023-02-08 | GOEDDEL DAVID V | director, 10 percent owner: | 11,370,274 | P-Purchase | A | 1,500,000 | 2.60 | 3,900,000.00 |
| 2023-01-19 | COLUMN GROUP III GP, LP | director | 9,870,274 | P-Purchase | A | 69,739 | 2.50 | 174,201.00 |
| 2023-01-19 | GOEDDEL DAVID V | director | 9,870,274 | P-Purchase | A | 69,739 | 2.50 | 174,201.00 |
| 2023-01-18 | COLUMN GROUP III GP, LP | director | 9,800,535 | P-Purchase | A | 135,688 | 2.52 | 341,432.00 |
| 2023-01-17 | COLUMN GROUP III GP, LP | director | 9,664,847 | P-Purchase | A | 49,463 | 2.49 | 123,395.00 |
| 2023-01-18 | GOEDDEL DAVID V | director | 9,800,535 | P-Purchase | A | 135,688 | 2.52 | 341,432.00 |
| 2023-01-17 | GOEDDEL DAVID V | director | 9,664,847 | P-Purchase | A | 49,463 | 2.49 | 123,395.00 |
| 2022-11-21 | Srivastava Deepak | director | 372,435 | P-Purchase | A | 230,769 | 2.60 | 599,999.00 |
| 2022-12-05 | Burroughs Amy L. | director | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2022-12-05 | Burroughs Amy L. | None | 0 | None | None | 0.00 | ||
| 2022-12-05 | Burroughs Amy L. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-11-17 | Casdin Eli | director | 6,078,860 | P-Purchase | A | 2,492,042 | 2.60 | 6,479,309.00 |
| 2022-11-17 | Casdin Eli | director | 1,354,111 | P-Purchase | A | 1,354,111 | 2.60 | 3,519,334.00 |
| 2022-11-17 | Casdin Eli | director | 1,354,111 | P-Purchase | A | 1,354,111 | 0.00 | 1,354.00 |
| 2022-11-21 | COLUMN GROUP III GP, LP | director | 9,615,384 | P-Purchase | A | 9,615,384 | 2.60 | 24,999,998.00 |
| 2022-11-21 | GOEDDEL DAVID V | director | 9,615,384 | P-Purchase | A | 9,615,384 | 2.60 | 24,999,998.00 |
| 2022-09-08 | Parschauer Karah Herdman | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-10 | Walsh Jeffrey T. | director: | 39,727 | A-Award | A | 39,727 | 0.00 | 0.00 |
| 2022-06-10 | Walsh Jeffrey T. | director | 39,727 | A-Award | A | 39,727 | 5.26 | 208,964.00 |
| 2022-06-10 | Stehman-Breen Catherine | director: | 39,727 | A-Award | A | 39,727 | 0.00 | 0.00 |
| 2022-06-10 | Stehman-Breen Catherine | director | 39,727 | A-Award | A | 39,727 | 5.26 | 208,964.00 |
| 2022-06-10 | Srivastava Deepak | director: | 39,727 | A-Award | A | 39,727 | 0.00 | 0.00 |
| 2022-06-10 | Lee June | director: | 39,727 | A-Award | A | 39,727 | 0.00 | 0.00 |
| 2022-06-10 | GOEDDEL DAVID V | director: | 39,727 | A-Award | A | 39,727 | 0.00 | 0.00 |
| 2022-06-13 | CHEN JIN-LONG | director: | 39,727 | A-Award | A | 39,727 | 0.00 | 0.00 |
| 2022-06-10 | CHEN JIN-LONG | director | 39,727 | A-Award | A | 39,727 | 5.26 | 208,964.00 |
| 2022-06-10 | Casdin Eli | director: | 39,727 | A-Award | A | 39,727 | 0.00 | 0.00 |
| 2022-06-10 | Williams R Sanders | director: | 39,727 | A-Award | A | 39,727 | 0.00 | 0.00 |
| 2022-06-10 | Williams R Sanders | director | 39,727 | A-Award | A | 39,727 | 5.26 | 208,964.00 |
| 2022-04-26 | Hoey Timothy | officer: Chief Scientific Officer | 198,646 | S-Sale | D | 1,353 | 10.13 | 13,706.00 |
| 2022-02-15 | Ali Faraz | director, officer: Chief Executive Officer | 401,390 | A-Award | A | 401,390 | 15.19 | 6,097,114.00 |
| 2022-02-15 | PATTERSON LEONE D | officer: Chief Fin. and Bus. Officer | 66,000 | A-Award | A | 66,000 | 15.19 | 1,002,540.00 |
| 2022-02-15 | Tingley Whittemore | officer: Chief Medical Officer | 141,000 | A-Award | A | 141,000 | 15.19 | 2,141,790.00 |
| 2022-02-15 | Hoey Timothy | officer: Chief Scientific Officer | 168,000 | A-Award | A | 168,000 | 15.19 | 2,551,920.00 |
| 2021-12-22 | Parschauer Karah Herdman | director | 19,495 | A-Award | A | 19,495 | 20.99 | 409,200.00 |
| 2021-12-22 | Parschauer Karah Herdman | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-11-19 | Lee June | director | 18,937 | A-Award | A | 18,937 | 21.65 | 409,986.00 |
| 2021-11-19 | Lee June | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-08-03 | COLUMN GROUP III GP, LP | 10 percent owner | 4,985,570 | C-Conversion | A | 4,956,842 | 0.00 | 0.00 |
| 2021-08-03 | COLUMN GROUP III GP, LP | 10 percent owner | 4,414,720 | C-Conversion | A | 4,389,282 | 0.00 | 0.00 |
| 2021-08-03 | COLUMN GROUP III GP, LP | 10 percent owner | 0 | C-Conversion | D | 533,781 | 0.00 | 0.00 |
| 2021-08-03 | COLUMN GROUP III GP, LP | 10 percent owner | 0 | C-Conversion | D | 4,209,755 | 0.00 | 0.00 |
| 2021-08-03 | COLUMN GROUP III GP, LP | 10 percent owner | 0 | C-Conversion | D | 213,306 | 0.00 | 0.00 |
| 2021-08-03 | Casdin Partners Master Fund, L.P. | 10 percent owner | 3,224,849 | P-Purchase | A | 850,000 | 15.00 | 12,750,000.00 |
| 2021-08-03 | Casdin Partners Master Fund, L.P. | 10 percent owner | 2,374,849 | C-Conversion | A | 2,374,849 | 0.00 | 0.00 |
| 2021-08-03 | Casdin Partners Master Fund, L.P. | 10 percent owner | 361,969 | C-Conversion | A | 361,969 | 0.00 | 0.00 |
| 2021-08-03 | Casdin Partners Master Fund, L.P. | 10 percent owner | 0 | C-Conversion | D | 2,012,880 | 0.00 | 0.00 |
| 2021-08-03 | Casdin Partners Master Fund, L.P. | 10 percent owner | 0 | C-Conversion | D | 361,969 | 0.00 | 0.00 |
| 2021-08-03 | Casdin Eli | director, 10 percent owner: | 3,224,849 | P-Purchase | A | 850,000 | 15.00 | 12,750,000.00 |
| 2021-08-03 | Casdin Eli | director, 10 percent owner: | 2,374,849 | C-Conversion | A | 2,374,849 | 0.00 | 0.00 |
| 2021-08-03 | Casdin Eli | director, 10 percent owner: | 361,969 | C-Conversion | A | 361,969 | 0.00 | 0.00 |
| 2021-08-03 | Casdin Eli | director, 10 percent owner: | 0 | C-Conversion | D | 2,012,880 | 0.00 | 0.00 |
| 2021-08-03 | Casdin Eli | director, 10 percent owner: | 0 | C-Conversion | D | 361,969 | 0.00 | 0.00 |
| 2021-08-03 | GOEDDEL DAVID V | director, 10 percent owner: | 4,985,570 | C-Conversion | A | 4,956,842 | 0.00 | 0.00 |
| 2021-08-03 | GOEDDEL DAVID V | director, 10 percent owner: | 4,414,720 | C-Conversion | A | 4,389,282 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
